Thinking like a consumer marketer allows you to discover patients’ mindsets, how they operate daily, and how they move through their lives. This approach can bring a higher level of empathy and authenticity that attracts patients rather than having to chase them. Following these suggestions can help create a patient-centric media strategy that will appeal to your target audience, so they can make better decisions to improve their care and quality of life.

In this virtual discussion, Jefferson Health’s Chief Growth and Marketing Officer will explore how to shift the culture to one that is hyper-focused on profitable growth that improves patient lives.

Patients are asking to join clinical trials of antibody-based Covid-19 drugs after U.S. President Donald Trump was treated with an experimental therapy from Regeneron Pharmaceuticals Inc.

A rheumatoid arthritis drug developed by Genentech proved to be effective in benefitting patients who have Covid-19-associated pneumonia, according to new late-stage clinical trial data.

EVERSANA launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies.

Bryen Pittner, a Strategic Planner for FCB Health New York, discusses how healthcare brands can reach patients meaningfully at three key touchpoints in a simple transactional journey.

According to a new study by Worldwide Partners, the effect that Covid-19 is having on digital health adoption is set to be transformative. The survey that was conducted shows technology is playing a crucial and growing role in mitigating the healthcare crisis, especially via telehealth.

Patients do not just want a doctor with a good bedside manner, according to new Everyday Health and Klick Health research exploring the growth of telemedicine and its increasing popularity with patients who continue to have healthcare needs, even in the midst of a pandemic and a socially distanced world.

Vineti and EVERSANA announced a partnership to improve access, affordability and patient support challenges in regenerative medicine.

German biotech company BioNTech and U.S. drugmaker Pfizer said they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.